FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells

FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells

Abstract Background Cervical cancer is one of the most common causes of cancer‐associated mortality among affected women in the world. At present, treatment with weekly cisplatin plus ionizing radiation (IR) therapy is the standard regimen for cervical cancer, especially for locally advanced cervica...

Full description

Bibliographic Details
Main Authors: Jin‐Li Li, Jian‐Ping Wang, Hong Chang, Sheng‐Ming Deng, Jia‐Hui Du, Xiao‐Xiao Wang, He‐Juan Hu, Dong‐Yin Li, Xiang‐Bin Xu, Wei‐Qiang Guo, Yao‐Hua Song, Zhigang Guo, Min‐Xuan Sun, Yi‐Wei Wu, Song‐Bai Liu
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Cancer Medicine
Subjects:
cervical cancer
FEN1
radiotherapy
targeted therapy
Online Access:https://doi.org/10.1002/cam4.2615

Internet

https://doi.org/10.1002/cam4.2615

Similar Items